Active Ingredient History
Medium-chain triglycerides (MCTs) are triglycerides with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms, i.e. medium-chain fatty acids (MCFAs). Rich food sources for commercial extraction of MCTs include palm kernel oil and coconut oil. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adenomatous Polyposis Coli (Phase 3)
Alcoholism (Phase 3)
alpha-Linolenic Acid (Phase 3)
Anti-Inflammatory Agents (Phase 3)
Atrial Fibrillation (Phase 3)
Blepharitis (Phase 4)
Carcinoma, Hepatocellular (Phase 2/Phase 3)
Cardiomyopathy, Dilated (Phase 3)
Cardiovascular Diseases (Phase 3)
Child Development (Phase 2)
Conjunctivitis (Phase 2)
Critical Illness (Phase 4)
Docosahexaenoic Acids (Phase 3)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Dry Eye Syndromes (Phase 4)
Eicosapentaenoic Acid (Phase 3)
Fatty Acids (Phase 3)
Fatty Liver (Phase 2)
Fibrosis (Phase 2/Phase 3)
Health Behavior (Phase 2)
Heart Failure (Phase 3)
Hypertriglyceridemia (Phase 4)
Inflammation (Phase 2)
Liver Cirrhosis (Phase 2/Phase 3)
Liver Neoplasms (Phase 4)
Maternal Exposure (Phase 2)
Multiple Sclerosis (Phase 1/Phase 2)
Obesity (Phase 3)
Obesity, Morbid (Phase 2)
Pancreatic Neoplasms (Phase 4)
Parenteral Nutrition (Phase 3)
Pressure Ulcer (Phase 4)
Preventive Health Services (Phase 3)
Preventive Medicine (Phase 3)
Prostatic Neoplasms (Phase 1/Phase 2)
SARS-CoV-2 (Phase 3)
Schizophrenia (Phase 4)
Stomach Neoplasms (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue